Topical application of the Hedgehog inhibitor patidegib in patients with Gorlin syndrome: a phase II trial.

Saved in:
Bibliographic Details
Title: Topical application of the Hedgehog inhibitor patidegib in patients with Gorlin syndrome: a phase II trial.
Authors: Lear JT; Department of Dermatology, Manchester Royal Infirmary, Manchester, UK.; Manchester Academic Health Science Centre, University of Manchester, Manchester, UK., Harwood CA; Royal London Hospital, Barts Health NHS Trust/Queen Mary University of London, London, UK., Hasan Z; Royal London Hospital, Barts Health NHS Trust/Queen Mary University of London, London, UK., Kentley J; Royal London Hospital, Barts Health NHS Trust/Queen Mary University of London, London, UK., Thomson J; Royal London Hospital, Barts Health NHS Trust/Queen Mary University of London, London, UK., Khoo A; Department of Dermatology, Manchester Royal Infirmary, Manchester, UK.; Manchester Academic Health Science Centre, University of Manchester, Manchester, UK., Alderman A; PellePharm, Inc., San Francisco, CA, USA., DeSouza M; PellePharm, Inc., San Francisco, CA, USA., Epstein EH Jr; PellePharm, Inc., San Francisco, CA, USA., Kochendoerfer GG; PellePharm, Inc., San Francisco, CA, USA., Tang JY; Department of Dermatology, Stanford University School of Medicine, Stanford, CA, USA.
Source: The British journal of dermatology [Br J Dermatol] 2025 Mar 18; Vol. 192 (4), pp. 611-617.
Publication Type: Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial; Multicenter Study
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print Cited Medium: Internet ISSN: 1365-2133 (Electronic) Linking ISSN: 00070963 NLM ISO Abbreviation: Br J Dermatol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1365-2133
DOI:10.1093/bjd/ljae444